The Small Molecules Innovator CDMO market is poised for a significant transformation as it is expected to reach a size of USD 80.04 billion by 2035, growing at a compound annual growth rate (CAGR) of 4.27%. This growth trajectory signals a robust demand for contract development and manufacturing services in the pharmaceutical industry, driven by the increasing complexity of drug formulations...